Sanket Shah, General Counsel of Mesa Laboratories Inc /CO/, filed an amended Form 3/A with the SEC on November 12, 2026, reporting initial beneficial ownership of 2,306 restricted stock units in the company's common stock as of November 10, 2026.

Key Highlights

  • Reporting person: Sanket Shah, identified as General Counsel of Mesa Laboratories Inc /CO/ (NASDAQ:MLAB)
  • Security disclosed: 2,306 Restricted Stock Units, each representing a contingent right to receive one share of common stock
  • Exercise price: $0 per RSU, held directly
  • Vesting schedule: 34% on November 10, 2027; 33% on November 10, 2028; and 33% on November 10, 2029
  • Event date: November 10, 2026, with the amendment filed November 12, 2026
  • No non-derivative securities: Table I reporting direct or indirect share holdings was left blank

Sanket Shah's Initial Beneficial Ownership at Mesa Laboratories

According to the filing, Sanket Shah, serving as General Counsel at Mesa Laboratories Inc /CO/ (NASDAQ:MLAB), reported an initial statement of beneficial ownership on an amended Form 3/A. The event requiring the statement was dated November 10, 2026, and the amendment was filed on November 12, 2026. The original Form 3 had been filed on November 12, 2026, as noted in the amendment field.

The filing disclosed one derivative security position: 2,306 Restricted Stock Units classified under Table II. The filing states that "each RSU represents a contingent right to receive one share of the Issuer's common stock." The conversion or exercise price is listed as $0, and the ownership form is direct. No non-derivative securities were reported in Table I, leaving that section blank.

The RSUs are set to vest in three installments: 34% on November 10, 2027, 33% on November 10, 2028, and 33% on November 10, 2029, according to the filing's explanatory footnotes. The filing was signed by John Sakys under Power of Attorney on behalf of Sanket Shah on November 12, 2026. Shah's address is listed as 12100 West Sixth Avenue, Lakewood, Colorado 80228.

What Was Disclosed

This amended Form 3/A reported General Counsel Sanket Shah's initial beneficial ownership of 2,306 RSUs in Mesa Laboratories Inc /CO/ common stock, with a three-tranche vesting schedule spanning 2027 through 2029 and no direct share holdings reported.